Skip to Main Content

Author Details

Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
2013
43
8
PMIDPaper TitleJournal TitlePublished Year
37979707Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for Localized High-Risk Prostate Cancer (pHART2-RCT).Int J Radiat Oncol Biol Phys2024
37951820Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office.Eur Urol Oncol2024
35948465Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes.Clin Oncol (R Coll Radiol)2023
38051188Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.Radiology2023
37284049Oligometastasis in Prostate Cancer: Can We Learn from Those "Excluded" from a Phase 2 Trial?Eur Urol Open Sci2023
37032280Late Toxicities of Prostate Radiotherapy: Can We Further SMARTen Up the Therapeutic Index?Eur Urol Focus2023
37265510Practice-based training strategy for therapist-driven prostate MR-Linac adaptive radiotherapy.Tech Innov Patient Support Radiat Oncol2023
36549968Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer.Brachytherapy2023
36737311Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy.Clin Oncol (R Coll Radiol)2023
32926325Enhancing International Cancer Organization Collaborations: King Hussein Cancer Center and Princess Margaret Cancer Centre Model for Collaboration.J Cancer Educ2022
35644708Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body Radiotherapy.Clin Oncol (R Coll Radiol)2022
35638085Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell Tumors.Eur Urol Open Sci2022
36244387Stereotactic Body Radiation Therapy for Oligometastasis: GUst Do It?Int J Radiat Oncol Biol Phys2022
36031465Extended Results and Independent Validation of a Phase 2 Trial of Metastasis-Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer.Int J Radiat Oncol Biol Phys2022
34919885FACE Value of Patient-Reported Outcomes in Dose-Escalated Radiation Therapy for Prostate Cancer.Int J Radiat Oncol Biol Phys2022
34812728Metastatic progression following multimodal therapy for unfavorable-risk prostate cancer.Can Urol Assoc J2022
34836735Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis.Clin Oncol (R Coll Radiol)2022
34774650Refining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Radiother Oncol2022
32926761Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?BJU Int2021
33685838Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.Eur Urol2021
33816005Implementation of Cardiac Stereotactic Radiotherapy: From Literature to the Linac.Cureus2021
33753302Mammographic Surveillance in Older Women With Breast Cancer in Canada and the United States: Are We Choosing Wisely?Pract Radiat Oncol2021
33775496Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer - Results from a Prospective Cohort Study.Clin Oncol (R Coll Radiol)2021
34487764Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials.Radiother Oncol2021
34324914Elective pelvic nodal irradiation with a simultaneous hypofractionated integrated prostate boost for localized high risk prostate cancer: Long term results from a prospective clinical trial.Radiother Oncol2021
34237473Moving Unfavorable Small-Bowel Anatomy Away From the Prostate to Optimize Radiation Therapy Plans With the GU-Lok.Pract Radiat Oncol2021
32327479[<sup>18</sup>F]DCFPyL PET-MRI/CT for unveiling a molecularly defined oligorecurrent prostate cancer state amenable for curative-intent ablative therapy: study protocol for a phase II trial.BMJ Open2020
31895403Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A Review.JAMA Oncol2020
31977380Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy.Cancer J2020
33123432Stereotactic Radiotherapy for Pancreatic Cancer: A Single-Institution Experience.Cureus2020
32553790Use of combined androgen deprivation therapy with postoperative radiation treatment for prostate cancer: Impact of randomized trials on clinical practice.Urol Oncol2020
30447404Improving Quality of Radiation Therapy Care Across Ontario using a Community-of-Practice Approach.Pract Radiat Oncol2019
32095546Case series illustrating the synergistic use of hydrogel spacer and MR-guidance to increase the radiotherapeutic index for localized prostate cancer.Tech Innov Patient Support Radiat Oncol2019
32529124The Capital Investment Strategy for Radiation therapy in Ontario: A Framework to Ensure Access to Radiation Therapy.Adv Radiat Oncol2019
30153435International Multicenter Validation of an Intermediate Risk Subclassification of Prostate Cancer Managed with Radical Treatment without Hormone Therapy.J Urol2019
30929849Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.Eur Urol Oncol2019
30625410A Phase 1 Pilot Study of Preoperative Radiation Therapy for Prostate Cancer: Long-Term Toxicity and Oncologic Outcomes.Int J Radiat Oncol Biol Phys2019
29594218The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP).Clin Transl Radiat Oncol2017
28163811Retroperitoneal hematoma following radical orchiectomy: Two cases.Can Urol Assoc J2017
27021496Shewanella algae bacteremia from a foot ulcer exposed to seawater during a Caribbean vacation.J Travel Med2016
26547383Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study.Int J Radiat Oncol Biol Phys2016
27219522PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer.Cancer2016
24141625Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response.Clin Cancer Res2013
  • 1 - 43 of 43

Recommended Authors

Audrey Dang
Tulane University School of Medicine
Career Start Year 2018
Number of shared co-authors 24
Ryan Phillips
Johns Hopkins University
Career Start Year 2017
Number of shared co-authors 12
Luca F Valle
University of California los angeles
Career Start Year 2016
Number of shared co-authors 15
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 10
Kiri A Sandler
Oregon Health and Science University
Career Start Year 2012
Number of shared co-authors 10
Stephen Greco
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 21
Ting Martin Ma
University of Washington
Career Start Year 2010
Number of shared co-authors 20
Xin Pei
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 3
Rebecca Levin-Epstein
University of California los angeles
Career Start Year 2010
Number of shared co-authors 28
Suneil Jain
Cancer Centre Belfast City Hospital, Queen's University Belfast
Career Start Year 2008
Number of shared co-authors 10
Bradley J Stish
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 23
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 17
Bridget F Koontz
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 18
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 10
Nicholas van As
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 7
Neil B Desai
University of Texas Southwestern Medical Center
Career Start Year 2004
Number of shared co-authors 18
Albert J Chang
University of California Los Angeles
Career Start Year 2003
Number of shared co-authors 23
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Chandana A Reddy
Cleveland Clinic
Career Start Year 2000
Number of shared co-authors 18
Drew Moghanaki
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 7
Daniel J Krauss
William Beaumont School of Medicine
Career Start Year 1999
Number of shared co-authors 16
Gert De Meerleer
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 13
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 17
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 11
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year 1991
Number of shared co-authors 22
Jeff M Michalski
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 23
Paul L Nguyen
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 32
Christopher R King
University of California los angeles
Career Start Year 1988
Number of shared co-authors 26
Mack Roach
University of California San Francisco
Career Start Year 1983
Number of shared co-authors 18
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Career Start Year 1976
Number of shared co-authors 26

Collaborators

Alejandro Berlin
University of Toronto, Princess Margaret Cancer Centre
Co-authored papers 17
Neil E Fleshner
University of Toronto
Co-authored papers 9
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 7
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 6
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 5
Robert G Bristow
University of Toronto
Co-authored papers 5
Michael Milosevic
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 4
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 3
Alexandre R Zlotta
University Health Network, Princess Margaret Cancer Center, University of Toronto
Co-authored papers 3
Girish S Kulkarni
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 3
Constantine A Mantz
University of Chicago
Co-authored papers 2
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 2
Richard P Hill
Princess Margaret Cancer Centre
Co-authored papers 2
Blaise A Clarke
University of Toronto.
Co-authored papers 2
Amar U Kishan
University of California los angeles
Co-authored papers 2
Alan W Katz
University of Rochester
Co-authored papers 2
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 2
Danielle Rodin
Princess Margaret Cancer Centre, University of Toronto
Co-authored papers 2
Donald B Fuller
Division of Genesis Healthcare Partners Inc., CyberKnife Centers of San Diego Inc.
Co-authored papers 2
Anthony Fyles
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 2
Stanley K Liu
Odette Cancer Centre, University of Toronto
Co-authored papers 2
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 2
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 2
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 2
Matthew P Deek
Rutgers Robert Wood Johnson Medical School, Rutgers University
Co-authored papers 1
Michael L Steinberg
University of California los angeles
Co-authored papers 1
Simeng Suy
MedStar Georgetown University Hospital
Co-authored papers 1
Robert T Dess
University of Michigan ann arbor
Co-authored papers 1
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 1
Joseph L Chin
University of Western Ontario
Co-authored papers 1
Release 1.2